Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Aimmune Therapeutics logo

Aimmune Therapeutics

Recent Finacing

Equity

Recent Raise

$98M

Aimmune Therapeutics is a Brisbane, California–based biotechnology company developing drug therapies for food allergies, notably a peanut allergy oral immunotherapy candidate undergoing regulatory review and clinical development.

Founded 2011
California, United States
251-500
Publicly Traded
aimmune.com

Highlights

Focus Areas

Biotechnology
Health Care
Pharmaceutical
Therapeutics

Recent Investors

Nestl Health Science logo
Longitude Capital logo
Foresite Capital logo
Palo Alto Investors logo
RA Capital Management logo
Aisling Capital logo
Fidelity Management & Research Company logo
Adage Capital Management logo
Food Allergy Research & Education logo

Financials

$340M

Total Raised

4

Funding rounds

9

Investors


Team

Upgrade to view the team

See the team members at Aimmune Therapeutics.